266 related articles for article (PubMed ID: 26010758)
1. Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
Verma M; Beaulieu-Abdelahad D; Ait-Ghezala G; Li R; Crawford F; Mullan M; Paris D
PLoS One; 2015; 10(5):e0128224. PubMed ID: 26010758
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.
Paris D; Beaulieu-Abdelahad D; Abdullah L; Bachmeier C; Ait-Ghezala G; Reed J; Verma M; Crawford F; Mullan M
Eur J Pharmacol; 2013 Jan; 698(1-3):145-53. PubMed ID: 23178521
[TBL] [Abstract][Full Text] [Related]
3. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
[TBL] [Abstract][Full Text] [Related]
4. Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.
Paris D; Beaulieu-Abdelahad D; Bachmeier C; Reed J; Ait-Ghezala G; Bishop A; Chao J; Mathura V; Crawford F; Mullan M
Eur J Pharmacol; 2011 Nov; 670(2-3):384-91. PubMed ID: 21958873
[TBL] [Abstract][Full Text] [Related]
5. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
7. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
[TBL] [Abstract][Full Text] [Related]
8. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
9. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
[TBL] [Abstract][Full Text] [Related]
10. Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.
Jiao SS; Yao XQ; Liu YH; Wang QH; Zeng F; Lu JJ; Liu J; Zhu C; Shen LL; Liu CH; Wang YR; Zeng GH; Parikh A; Chen J; Liang CR; Xiang Y; Bu XL; Deng J; Li J; Xu J; Zeng YQ; Xu X; Xu HW; Zhong JH; Zhou HD; Zhou XF; Wang YJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5225-30. PubMed ID: 25847999
[TBL] [Abstract][Full Text] [Related]
11. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
13. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
Huang W; Li Z; Zhao L; Zhao W
Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
[TBL] [Abstract][Full Text] [Related]
15. Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease.
Filali M; Lalonde R; Rivest S
Physiol Behav; 2011 Oct; 104(5):880-5. PubMed ID: 21640739
[TBL] [Abstract][Full Text] [Related]
16. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
18. Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer׳s disease through Akt/CREB and GSK-3β phosphorylation in the brain.
Jeon S; Park JE; Lee J; Liu QF; Jeong HJ; Pak SC; Yi S; Kim MH; Kim CW; Park JK; Kim GW; Koo BS
J Ethnopharmacol; 2015 Feb; 160():69-77. PubMed ID: 25457987
[TBL] [Abstract][Full Text] [Related]
19. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
20. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
